Anacetrapib: Merck New Cholesterol-Lowering Drug

Anacetrapib: Merck New Cholesterol-Lowering Drug – There has been a recent study which strongly suggests that a Merck experimental drug can significantly improve cholesterol levels, something which few other drugs have been able to accomplish with any measure of success. The drug raises “good” cholesterol levels and prevents heart disease, one of the leading global killers in both first and third world countries.

The study which was presented to the American Heart Association discovered that a drug called anacetrapib did not increase the chances of suffering a cardiovascular event such as a heart attack or stroke.

The study on this drug consisted of 1,600 different people and found that there was no change in the person’s blood pressure or electrolytes. Merck said that if everything goes according to plan, the data which they are gathering might be able to get them to where they want to be in terms of the highly anticipated 30,000 person study.

It would certainly be one of the larger studies launched to discover the effects that a drug like this has on a person’s cholesterol. It is proving to be one of the most revolutionary findings of the year and has many researchers excited to get started with the research that is currently being planned.

Leave a Comment